SCHEMBL25829767

SCHEMBL25829767

COc1cccc(F)c1-c1c(F)cc2c3c(c(=O)n(-c4c(C)ccnc4C(C)C)c2c1F)N(C)C(=O)[C@H]1CN(C(=O)OC(C)(C)C)[C@H](C)CN31

nearest known ligand 0.43

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
KRAS P01116 20/20 0.43
SOS1 Q07889 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24692579 0.95 KRAS (0.44) KRAS
SCHEMBL25830155 0.93 KRAS (0.44) KRAS
SCHEMBL23136633 0.93 KRAS (0.38) KRAS
SCHEMBL25830099 0.93 KRAS (0.41) KRASSOS1
SCHEMBL25829947 0.92 KRAS (0.48) KRASSOS1
SCHEMBL25829786 0.91 KRAS (0.40) KRASSOS1
SCHEMBL25830096 0.91 KRAS (0.41) KRASSOS1
SCHEMBL25829931 0.90 KRAS (0.45) KRAS
SCHEMBL24692093 0.90 KRAS (0.43) KRAS
SCHEMBL25830054 0.90 KRAS (0.39) KRASSOS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230227472-A1 FUSED PYRIDONE COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF SHANGHAI JEMINCARE PHARMACEUTICALS CO., LTD (CN) 2023-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230227472-A1 FUSED PYRIDONE COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF KRAS, NRAS, WEE1 KRAS 1/4885SOS1 154/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.